GLP-1 Weight Management (semaglutide)
GLP-1 Weight Management (semaglutide)
Starting at
$349
/month- We're sorry, but to buy this product you need to complete the questionnaire
- We're sorry, but to buy this product you need to update your weight information in the questionnaire.
- you are under 18 years of age
- you are pregnant or nursing
- your BMI does not meet the required qualifications
- your BMI does not meet the required qualifications
- you reside in a currently unsupported state
- you have history of type 1 diabetes
- you have history of diabetic retinopathy
- you have history of MEN-2 disease
- you reside outside of the United States
- We're sorry, but you are not eligible for this product because you already have an active subscription for weight management product.
- We're sorry, but Qyral Weight Management products are no longer available in Mississippi.
Lose up to 15%+
Semaglutide: In 3 separate clinical trials involving non-diabetic patients, individuals who received semaglutide at a dose of 2.4 mg/week, along with following a reduced-calorie diet and increasing physical activity, experienced an average weight loss of 15% of their body weight over the course of 68 weeks. Source: https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
90 day supply, billed monthly
Option to renew every 3 months
Option to cancel every 3 months
Doctor review: 1-2 days
Processing: Up to 15-20 days
(subject to pharmacy partners)
Shipping: overnight
GLP-1 Weight Management (semaglutide) includes doctor & medication with no hidden fees or insurance required
- Personalized prescription appetite suppression: Semaglutide curbs appetite and reduces food cravings, promoting weight loss.
- Scientifically backed weight loss aid: Semaglutide is an effective weight loss aid, as demonstrated in clinical trials where some patients shed up to 15% of their body weight over 68 weeks.
- Metabolic health booster: Semaglutide improves metabolic health by lowering blood sugar levels, improving insulin sensitivity, and decreasing the risk of health problems that often accompany obesity such as type 2 diabetes, high blood pressure, and cardiovascular disease.
- Enhanced quality of life: Semaglutide assists in reaching a healthy weight, which can reduce symptoms like fatigue and joint pain linked to excess weight. It also improves mobility and boosts energy levels.
* The total mg of may vary depending on the pharmacy and state providing services.
** Typical patient dosing schedule. A licensed doctor will determine your final dose and schedule after your consultation.
Pricing is per month and entails a 3-month minimum commitment.
TIER 1
$349
/monthTIER 2
$399
/monthTIER 3
$449
/monthYou will be able to switch the tier every 3 months during regular assessment based on your progress and goals.
*Your dosing plan might vary based on the recommendations from a doctor on the Qyral platform. Total units in vials vary by pharmacy, you will always receive enough for the given dosing schedule.
** For patients returning to the Weight Management Program after a break, we will initiate their treatment with the initial dosing plan (Tier 1). This is a standard procedure to ensure safety and effectiveness, regardless of the dosing tier they were on before leaving the program.
GLP-1 is a hormone that is naturally produced in the body and is involved in regulating blood sugar levels. However, it has also been found to play a role in appetite regulation and weight management. GLP-1 receptor agonists are medications that mimic the effects of GLP-1 in the body and can be used for weight loss. These drugs work by reducing appetite, increasing feelings of fullness, and slowing down the emptying of the stomach which helps reduce caloric intake and leads to weight loss. In addition to promoting weight loss, GLP-1 receptor agonists have been shown to improve blood sugar control, lower blood pressure and cholesterol levels, and reduce the risk of cardiovascular disease. They also have a lower risk of causing hypoglycemia compared to other weight loss medications, making them a safer option for people with type 2 diabetes who are also struggling with obesity. Overall, GLP-1 receptor agonists are a promising new class of medications for weight loss and improving metabolic health.
If approved, physicians on the Qyral platform prescibe compounded semaglutide. Scientifically proven to activate GLP-1 receptors, semaglutide effectively reduces appetite and promotes weight loss. Depending on your prescription, the state and region, our product may also include additional ingredients such as Vitamin B6, Vitamin B12, Carnitine, or an equivalent, for added metabolic support.
Compounded semaglutide injections must be used with caution and under the guidance of a healthcare professional. It is important to follow a doctor's instructions regarding dosage, timing, and administration of the medication. Always read the instructions provided by the pharmacy carefully and ask any questions you may have before using the medication. It is essential to never alter the dosage or frequency of semaglutide injections without consulting a doctor first.
FREQUENTLY ASKED QUESTIONS
Semaglutide is used for the treatment of type 2 diabetes and long-term weight management.
If approved, a licensed provider on the Qyral platform may prescribe a compounded version of semaglutide, which may also include additional metabolic support ingredients such as Vitamin B6, Vitamin B12, Carnitine, or an equivalent, depending on the state and region and your individual medical history and assessment by the licensed healthcare provider. The pharmacy that will ship to you depends on your state of residence, and each pharmacy that Qyral partners with may also use its own unique set of metabolic support ingredients in compounding the medication. Therefore, depending on the state and your licensed healthcare provider’s assessment, you may receive different metabolic support ingredients from the corresponding pharmacy.
Semaglutide for weight loss works by reducing appetite and increasing feelings of fullness. It mimics the activity of GLP-1 (glucagon-like peptide-1), a hormone naturally released by your gut in response to food. GLP-1 helps regulate appetite and blood sugar levels in the body.
At Qyral, a provider from our network of licensed providers may prescribe a compounded version of semaglutide with B12 (or equivalent). The semaglutide is compounded in a pharmacy using only the highest quality ingredients. It's important to note that the semaglutide prescribed by these physicians is not associated with the Novo Nordisk company or the brand-name medications Wegovy or Ozempic.
Choosing a compounded medication over brand-name medications can result in significant cost savings, as brand-name medications can be expensive and cost thousands of dollars. Additionally, one of the benefits of compounded pharmaceuticals is that your healthcare provider can customize the dosage specifically to your individual needs. This personalized approach can lead to more effective treatment outcomes.
Semaglutide is generally considered safe when used as directed and under the supervision of a healthcare provider. However, like any medication, it can have potential side effects. Some common side effects of semaglutide include nausea, vomiting, diarrhea, and constipation. These side effects are usually mild and go away over time. In rare cases, more serious side effects can occur. (Source)
It is important to talk to your healthcare provider about any potential risks and benefits of taking semaglutide, to ask any questions you have about weight management treatment and potential side effects, and to report any side effects or concerns immediately.
To use a compounded medication containing semaglutide, there are specific criteria that must be met. Your licensed healthcare provider will confirm that the following is true and accurate before prescribing a compounded medication: You must:
1. Be at least 18 years old.
2. Reside in or physically be located in one of the states where services are available.
3. Demonstrate the need for medical treatment. If necessary, our team can assist you in obtaining recent lab results if requested by your healthcare provider.
4. Meet the FDA-approved criteria for these medications, which include having a body mass index (BMI) over 30 for individuals with obesity, and a BMI over 27 with a qualifying health condition such as type 2 diabetes, high blood pressure, or high cholesterol.
5. Not have any of the following conditions: Type 1 Diabetes, a history of chronic pancreatitis or pancreatitis caused by weight loss medications (GLP-1), severe gastrointestinal (GI) disease, current gallbladder problems (excluding previous gallbladder removal/cholecystectomy), retinal impairment/diabetic retinopathy, bariatric surgery within the past 6 months, multiple endocrine neoplasia syndrome type 2 (MEN-2), or a history of medullary thyroid cancer.
6. Not be pregnant or nursing.
A licensed healthcare provider will make the final determination regarding your qualification for the Weight Management Program and may require additional information from you directly to make a final determination and assess your individual situation.